FDA.reportPublic FDA data

BHI Skin Tablet

Manufacturer
MediNatura Inc
Effective date
2022-07-07
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:17:40

Label at a glance#

ProductBHI Skin
Active ingredientBERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, SULFUR
Label structure8 sections

Indications and uses

For the temporary relief of minor eczema symptoms: rough scaly skin, itching skin, redness

Dosage and administration

At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage.  Standard dosage: Adults and children 4 years and older: Take 1-2  tablet every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 4, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Each tablet contains: *Berberis vulgaris 6X, Graphites 10X, Hydrofluoricum acidum 10X, *Lycopodium clavatum 12X, *Petroleum 10X, *Rhus toxicodendron 8X, *Sepia 10X, *Sulphur 12X 37.5 mg each.

*Natural Ingredients

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Dextrose,  Magnesium Stearate, Maltodextrin

PURPOSE

OTC - PURPOSE SECTION

Eczema Relief Tablets

Relieves:

• Rough Scaly Skin

• Itching Skin

• Redness

USES

INDICATIONS & USAGE SECTION

For the temporary relief of minor eczema symptoms: rough scaly skin, itching skin, redness

Directions

DOSAGE & ADMINISTRATION SECTION

At first sign of symptoms:Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. 

Standard dosage: Adults and children 4 years and older: Take 1-2 tablet every 4 to 6 hours. Do not exceed 12 tablets in 24 hours.For children under 4, consult your health professional.

Allow tablets to dissolve completely in the mouth, do not swallow.

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Skin or any of its ingredients exists.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

BHI Skin TabletBHI Skin Tablet

Add image transcription here...

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62795-1016-3BHI Skin100 in 1 PACKAGETABLET1004
62795-1016-3BHI Skin1 in 1 CARTONTABLET14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62795-1016BHI SKIN (BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR) TABLET [MEDINATURA INC]4Current NDC, Legacy NDC, 2 package rows20220708_70ab2931-bd2d-43de-bb36-d019f78e3d73.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62795-1016-2EA - Each62795-1016909392b7-a0cc-408a-9e85-868cf6c95e0f12015-10-02
62795-1016-3EA - Each62795-1016473c4f93-b8da-4e36-bc1d-93fb1afb26e312023-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BERBERIS VULGARIS ROOT BARKACTIVE INGREDIENT1TH8Q20J0U1
GRAPHITEACTIVE INGREDIENT4QQN74LH4O1
HYDROFLUORIC ACIDACTIVE INGREDIENTRGL5YE86CZ1
LYCOPODIUM CLAVATUM SPOREACTIVE INGREDIENTC88X29Y4791
PETROLATUMACTIVE INGREDIENT4T6H12BN9U1
SEPIA OFFICINALIS JUICEACTIVE INGREDIENTQDL83WN8C21
SULFURACTIVE INGREDIENT70FD1KFU701
TOXICODENDRON PUBESCENS LEAFACTIVE INGREDIENT6IO182RP7A1
BERBERIS VULGARIS ROOT BARKACTIVE MOIETY1TH8Q20J0U1
FLUORIDE IONACTIVE MOIETYQ80VPU408O1
GRAPHITEACTIVE MOIETY4QQN74LH4O1
LYCOPODIUM CLAVATUM SPOREACTIVE MOIETYC88X29Y4791
PETROLATUMACTIVE MOIETY4T6H12BN9U1
SEPIA OFFICINALIS JUICEACTIVE MOIETYQDL83WN8C21
SULFURACTIVE MOIETY70FD1KFU701
TOXICODENDRON PUBESCENS LEAFACTIVE MOIETY6IO182RP7A1
LACTOSEINACTIVE INGREDIENTJ2B2A4N98G1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62795-101662795-1016-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
BERBERIS VULGARIS ROOT BARK1TH8Q20J0UACTIB
GRAPHITE4QQN74LH4OACTIB
HYDROFLUORIC ACIDRGL5YE86CZACTIM
LYCOPODIUM CLAVATUM SPOREC88X29Y479ACTIB
PETROLATUM4T6H12BN9UACTIB
TOXICODENDRON PUBESCENS LEAF6IO182RP7AACTIB
SEPIA OFFICINALIS JUICEQDL83WN8C2ACTIB
SULFUR70FD1KFU70ACTIB
MAGNESIUM STEARATE70097M6I30IACT
MALTODEXTRIN7CVR7L4A2DIACT
DEXTROSEIY9XDZ35W2IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 4 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LACTOSELACTOSEJ2B2A4N98GTABLET / ORAL2500 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BHI SkinBERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFURMediNatura Inc70ab2931-bd2d-43de-bb36-d019f78e3d732022-07-07WarningsExact identifier
ndc (package): 62795-1016-3
ndc (product): 62795-1016
ndc11 (package): 62795101603
spl id: 29e7a2ad-a3bb-4527-a81d-0c6b4dba65a5
spl set id: 70ab2931-bd2d-43de-bb36-d019f78e3d73

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.